6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	AnorTech to Receive Cash and Equity from Corporate Transaction on the Sarfartoq Rare Earth Project
1m ago	D. Boral Capital Acted as Exclusive Placement Agent to LanzaTech Global, Inc. (Nasdaq:LNZA) in Connection with its $20,000,000 Registered Direct Offering
1m ago	Bulletin from the Annual General Meeting in Cantargia AB (publ)
3m ago	Centurion Initiates Exploration on Limestone Gold Project
4m ago	Yatra Online, Inc. to Host Fourth Quarter and Full Year 2026 Financial Results Call on May 25, 2026

About

1,570.50JPY+50.50 +3.32%

Closed • Updated at 15:03 GMT+00:00

Market Cap$4.29B

P/E Ratio5.84

Volume6.88M

Beta0.90

RSI37.23

Gross Margin56.67%

Health TechnologyPharmaceuticals: Major

Sumitomo Pharma Co.ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

Sumitomo Pharma America Announces that its Investigational Therapy DSP-3077 Has Received FDA Orphan Drug Designation for the Treatment of Retinitis Pigmentosa

Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition

Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting

Knight Therapeutics Announces Relaunch of ORGOVYX® in Canada

Knight Therapeutics Announces Relaunch of MYFEMBREE® in Canada

Community Chat

Ask AI